Physician profile
Anthony P Volpe
NPI 1801900824
$635.67
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.14 · 2020: $224 · 2021: $285 · 2022: $14.65 · 2024: $16.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $144.52 | 2020-2022 | |
| Amgen INC. | $76.67 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $72.60 | 2019-2021 | |
| Janssen Biotech, INC. | $57.97 | 2020-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $40.46 | 2021 | |
| Incyte Corporation | $39.75 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $29.03 | 2020-2021 | |
| Novocure INC. | $21.74 | 2019 | |
| Bioventus LLC | $16.46 | 2024 | Exogen Ultrasound Bone Healing System |
| Bayer Healthcare Pharmaceuticals INC. | $15.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.96 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $14.50 | 2021 | |
| Emd Serono, INC. | $14.40 | 2021 | |
| Amarin Pharma, INC. | $14.11 | 2020 | |
| Abbvie INC. | $13.84 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.23 | 2021 | |
| Tg Therapeutics, INC. | $12.14 | 2021 | |
| Seagen INC. | $12.11 | 2020 | |
| Sun Pharmaceutical Industries INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Volpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.